The FDA is introducing a new priority voucher program designed to shorten the drug review process from 10 to 12 months down to one or two months, according to the agency. The federal outfit's "Commissioner's National Priority Voucher" (CNPV) program will include a "limited number of vouchers" for "companies aligned with U.S. national priorities," according to a June 17 press release.
The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions align with the agency's national health priorities. www.statnews.com/2025/06/17/f ...
-- STAT (@statnews.com) Jun 17, 2025 at 12:15 PM
[image or embed]
Drudge Retort Headlines
Killing Democracy (123 comments)
Texas Dems Flee State Amid National Redistricting Battle (63 comments)
Putin Shows no Sign of Making Concessions (53 comments)
Poll Shows Widespread Disapproval and Suspicion of Trump's Handling of Epstein Files (46 comments)
The Fight for Fair Elections (25 comments)
'Not a Damned Penny' Texas Flood Survivors Look for Help (25 comments)
Brutal Arrest of Black Student in Florida (25 comments)
Las Vegas is Down on its Luck (22 comments)
Nuclear Reactor on the Moon (18 comments)
CBO: 'Big Ugly Bill' Will Add $5 Trillion to the Deficit (17 comments)